---
title: "BriaCell Therapeutics tumbles 10% during regular trading on melanoma vaccine milestone"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296809040.md"
description: "BriaCell Therapeutics (BCTX) tumbled 10% despite its personalized melanoma vaccine Bria-MEL+ hitting a key genetic engineering milestone."
datetime: "2026-08-24T15:43:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296809040.md)
  - [en](https://longbridge.com/en/news/296809040.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296809040.md)
generator: "portal-rs"
---

# BriaCell Therapeutics tumbles 10% during regular trading on melanoma vaccine milestone

BriaCell Therapeutics(BCTX.US) 盘中跌近**10%**，现报**3.67 美元**。

公司个性化黑色素瘤疫苗 Bria-MEL+ 近期达成基因工程关键里程碑，但市场反应负面。

### Related Stocks

- [BCTX.US](https://longbridge.com/en/quote/BCTX.US.md)

## Related News & Research

- [BriaCell says Bria-MEL+ melanoma vaccine candidate hits genetic engineering milestone](https://longbridge.com/en/news/296780600.md)
- [BriaCell subsidiary BriaPro reports $1.32M assets, $299,950 cash after sCD80 license acquisition](https://longbridge.com/en/news/291003611.md)
- [BriaCell publishes investor presentation on Bria-IMT immunotherapy program for metastatic breast cancer](https://longbridge.com/en/news/293362866.md)
- [BriaCell publishes investor presentation on Bria-IMT pivotal Phase 3 metastatic breast cancer program](https://longbridge.com/en/news/290262738.md)
- [BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026 | BCTX Stock News](https://longbridge.com/en/news/287354495.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**